JPEO-CBRND RFI - Genomic Sequencing Workflows
Type: Special Notice
Overview

Buyer

DEPT OF DEFENSE

Original Source

https://sam.gov/workspace/contract/opp/407323b61894404dbc7b3e46ca2cf216/view
Timeline
    Description

    The Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is issuing a Request for Information (RFI) to gather insights on end-to-end untargeted genomic sequencing workflows suitable for military applications. The RFI seeks to identify industry capabilities in developing genomic sequencing workflows, field-deployable bioinformatics tools, test and evaluation infrastructure, and protein toxin sequencing capabilities, all tailored for military users with varying technical expertise. This initiative is crucial for enhancing military readiness and response to biological threats through advanced genomic technologies. Interested parties are invited to submit their responses by January 9, 2026, with an Industry Day scheduled for January 29, 2026, at the SPA, Crown Center Conference Facility in Lorton, VA. For more information and to respond, please visit the Joint Enterprise Technology Tool (JETT) page.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    JPEO-CBRND RFI - Genomic Sequencing Workflows
    Currently viewing
    Special Notice
    Similar Opportunities
    RFI for Joint Project Manager for Chemical, Biological, Radiological and Nuclear Protection (JPM CBRN P) Hazard Mitigation
    Dept Of Defense
    The Department of Defense, specifically the Joint Project Manager for Chemical, Biological, Radiological and Nuclear Protection (JPM CBRN P), is conducting a Request for Information (RFI) to identify decontaminant technologies capable of mitigating hazardous contamination. The objective is to gather information on tactical and operational decontaminants that can effectively reduce health risks from chemical and biological agents, allowing warfighters to maintain operational readiness. This initiative is crucial for ensuring the safety and effectiveness of military personnel in contaminated environments. Interested vendors are invited to submit a summary of their technologies by January 23, 2026, to Lorraine Cline at lorraine.m.cline.civ@army.mil or Veronica St. Claire at veronica.a.stclaire.civ@army.mil, with detailed specifications and efficacy data included in their responses.
    JPEO-CBRND CWMD BOTAA-24-01
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEPT OF THE ARMY: The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking funding through Other Transaction Authority agreements (OTAs) for prototype and follow-on production projects within JPEO-CBRND mission areas of interest. The service being procured is the development of enabling technologies that speed up the advanced development process. This opportunity is open to all eligible sources, including educational institutions, nonprofit organizations, and private industry. Proposals are to be submitted in accordance with the provided guidelines. For more information, please refer to the JPEO-CBRND website.
    Request for Information (RFI) - BIQ Industry Day Announcement
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is hosting an Industry Day focused on Biocontainment, Isolation, and Quarantine (BIQ) requirements, scheduled for February 11–12, 2026, in Stafford, Virginia. This event aims to engage industry members regarding the Biological Containment Isolation System (BCIS), Portable Patient Transport System (PPTS), and Shipboard Isolation System (SIS), facilitating discussions on current and future needs while gathering market research on existing technologies. These systems are critical for providing safe transport and isolation of individuals with highly contagious infectious diseases (HCIDs) in various environments, including field and shipboard settings. Interested participants must register via the Joint Enterprise Technology Tool (JETT) by January 28, 2026, with foreign attendees required to register by January 8, 2026. For further inquiries, contact Peter W. Stahley at peter.w.stahley.civ@army.mil or Dan Adams at dan.l.adams2.civ@mail.mil.
    Request for Information (RFI) - Electrochemiluminescence (ECL) Multiplex Assay Kits
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is conducting a Request for Information (RFI) to identify industry partners capable of providing electrochemiluminescence (ECL) multiplex assay kits. These kits are essential for the identification of microbial toxins, including Ricin, Botulinum, and Staphylococcal Enterotoxin B (SEB), and must be compatible with government-furnished antibodies as well as Meso Scale Diagnostics (MSD) PR2 1800 and/or SQ 120 analyzers. This RFI serves as a market research tool and is not a solicitation for contract award; interested firms are required to submit their responses by January 16, 2026, including relevant company data and technical capabilities. For further inquiries, interested parties may contact Jemel Hogan at jemel.m.hogan.civ@army.mil or Sarah Eggerling at sarah.e.eggerling.civ@army.mil.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    Request for Information (RFI) - Electrochemiluminescence Analyzers and Consumables
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Contracting Command at Aberdeen Proving Ground, has issued a Request for Information (RFI) to gather industry capabilities for providing electrochemiluminescence analyzers and associated consumables. The primary objective is to identify systems capable of detecting microorganisms, viruses, and microbial toxins, with a critical requirement that the consumable assays can utilize government-furnished capture and detection antibodies. This procurement is essential for enhancing the Army's capabilities in biological detection and analysis. Interested firms are invited to submit their company information and technical capabilities by 5:00 PM EDT on January 16, 2026, to Jemel Hogan and Sarah Eggerling, as this RFI is for planning purposes only and does not constitute a solicitation for a contract.
    Brand Name Illumina reagents, kits and consumables (BPA)
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking sources for brand name Illumina reagents, kits, and consumables through a Sources Sought notice. The procurement aims to acquire products that are fully compatible with Illumina sequencing platforms, which are critical for high-throughput sequencing workflows utilized in microbial surveillance, viral detection, influenza typing, and gene expression profiling. The selected products must meet specific requirements, including validated protocols, unique dual indexing systems, tagmentation-based library preparation, validated shelf life, local technical support, and temperature-sensitive shipping. Interested parties can reach out to John Fitzsimmons at john.l.fitzsimmons8.civ@health.mil for further information regarding this opportunity.
    Chemical Biological Mask Equipment Tester (CBMET) Modernization Effort
    Dept Of Defense
    The Department of Defense, specifically the Army's Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is soliciting proposals for the modernization of the Chemical Biological Mask Equipment Tester (CBMET) portfolio. The objective is to develop a consolidated testing solution that assesses mask fit, serviceability, and performance for current and future CBRN protective masks, addressing issues of obsolescence and material shortages. This initiative is crucial for enhancing military personnel's operational effectiveness against Weapons of Mass Destruction (WMD) and improving defense capabilities. Interested parties must submit pre-proposals electronically by 5:00 PM EST on January 9, 2026, to both Emily McGill and Jemel Hogan, with further details available in the attached Statement of Objectives and the CWMD BOTAA documentation.
    BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), has issued a Broad Agency Announcement (BAA) to solicit proposals for innovative research and development in chemical, biological, radiological, nuclear, and explosive (CBRNE) defense capabilities. This solicitation is open continuously for up to five years and invites proposals from educational institutions, nonprofit organizations, and private industry, focusing on areas such as detection technologies, modeling and simulation, and countermeasures to terrorism. The BAA is crucial for enhancing national defense capabilities and ensuring the Joint Warfighters' dominance on the battlefield and homeland defense. Interested parties can contact Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil or Lionel Love at lionel.d.love.civ@army.mil for further information regarding proposal submissions and evaluation criteria.
    BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is conducting market research for the development of a barrier combination product aimed at preventing and treating battlefield wounds and subsequent infections. This initiative, part of the Battlefield Wound Infection Prevention and Treatment (BWI P&T) program, seeks to identify commercial solutions that can effectively address the unique challenges of wound care in austere environments, where medical resources may be limited. The barrier combination product is expected to play a crucial role in a Family of Systems (FoS) approach, providing innovative solutions for both military and commercial applications in wound care. Interested parties are invited to submit their responses by January 20, 2026, at 2:00 PM Eastern, via email to the primary contacts, Jeanette Collins and Julie Burns, whose emails are provided in the opportunity overview. This RFI is for planning purposes only, and no contract will be awarded based on the responses received.